MedDataX Logo

Evolution of a Novel Optical Coherence Tomography Based Index in Diagnosing Keratoconus

NCT ID: NCT06152484

Last Updated: 2023-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-01

Study Completion Date

2024-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of corneal topography based on oct OCT principle (CASIA2) with Pentacam and Scheimpflug-based biomechanical devices (Corvis ST) in screening and diagnosing keratoconus; and evaluation of the consistency with Pentacam in measuring corneal parameters (such as curvature and thickness).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Scansys, Pentacam, Keratoconus, Subclinical Keratoconus

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Scansys, Pentacam, Keratoconus, subclinical keratoconus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal control group

Pentacam, Corvis ST and CASIA2

Intervention Type OTHER

morphological and biomechanical parameters of corneal were obtain by CASIA2, Pentacam and Corvis ST

Subclinical keratoconus

Pentacam, Corvis ST and CASIA2

Intervention Type OTHER

morphological and biomechanical parameters of corneal were obtain by CASIA2, Pentacam and Corvis ST

Keratoconus

Pentacam, Corvis ST and CASIA2

Intervention Type OTHER

morphological and biomechanical parameters of corneal were obtain by CASIA2, Pentacam and Corvis ST

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pentacam, Corvis ST and CASIA2

morphological and biomechanical parameters of corneal were obtain by CASIA2, Pentacam and Corvis ST

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Best corrected visual acuity (BCVA) ≥ 20/20;
2. No other eye diseases except myopia and astigmatism;
3. The cornea was transparent, and there was no cloud or pannus;

Exclusion Criteria

1. The presence of ocular diseases other than myopia and keratoconus;
2. Ocular trauma;
3. Previous ocular surgery; 4 Patients were required to stop wearing soft contact lenses for at least 2 weeks and rigid contact lenses for at least 4 weeks before examination; 6. Pregnant and lactating women;
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tianjin Eye Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yan Wang, Prof

Role: STUDY_CHAIR

Tiajin Eye Hospita

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tiajin Eye Hospital

Tianjin, Tianjin Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shuangcheng Li, Master

Role: CONTACT

Phone: 022-27313336-7539

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KY2023063

Identifier Type: -

Identifier Source: org_study_id